One study found that the exosome-related CRABP2 is upregulated and promotes cell proliferation in ovarian cancer, and CRABP2 performs better than the currently used biomarker, CA125, in the diagnosis of ovarian cancer [23]. This evidence concerns the gene CRABP2 and ovarian carcinoma.